Cassava Sciences | PTIE - 운영 비용





운영 비용 변화 날짜
Abbott USD 10.46B 1.15B 2026-06
Amgen USD 11.69B 6.9B 2026-06
Biogen USD 2.98B 1.02B 2026-06
Cara Therapeutics USD 7.05M 1.11M 2026-03
Cassava Sciences USD 11.17M 2.38M 2026-03
Eisai JPY 209.6B 6.14B 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Geron USD 52.07M 6.73M 2026-03
J&J USD 17.83B 388M 2026-06
Merck USD 15.77B 2.4B 2026-06
Novartis USD 10.2B 912M 2026-06
Novavax USD 126.2M 23.62M 2025-12
Pfizer USD 85.19B 4.91B 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06